Indoleamine 2,3-dioxygenase (IDO1) is primarily located in microglia, which suggests that it can have a role in a range of neurodegenerative diseases, e.g., Alzheimer's and Parkinson's, plus mental disorders, including depression and schizophrenia [70]. Here, IDO1 is linked to depressive symptom measurement.